BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Europabio
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20221201T143000
DTEND;TZID=Europe/Brussels:20221201T160000
DTSTAMP:20260707T183506
CREATED:20221117T151753Z
LAST-MODIFIED:20221121T110237Z
UID:5532-1669905000-1669910400@www.europabio.org
SUMMARY:EuropaBio Patient BioForum 2022: Toward a Common Understanding of Unmet Medical Needs
DESCRIPTION:EuropaBio’s Patient BioForum meets annually to facilitate the exchange of views and expertise on scientific\, regulatory\, and policy issues between patient organisations and the biopharmaceutical industry. \n\n\n\nIn recent years\, unmet medical needs have been at the core of Europe’s pharmaceutical and public health policies. Addressing unmet medical need was outline as a central to the 2020 Pharmaceutical Strategy for Europe. One perceived shortcoming of the current legislative frameworks is insufficient stimulated development in some areas of ‘unmet medical need’ (UMN) such as antimicrobial resistance or rare diseases. The upcoming revision of the EU pharmaceutical legislation and orphan and paediatric legislation will aim at addressing “unmet medical needs”. \n\n\n\nA major hurdle to overcome is reaching a common understanding of unmet medical needs as stakeholders have different understanding of the concept based on different perceptions and expectations. Unmet medical need is scientific concept which can be used to identify patient and societal health needs and stimulate research activities. As science progresses\, and with it the knowledge to address unmet medical needs\, these needs will evolve over time from improving mortality\, modifying disease progression\, improving quality of life\, burden of the disease\, and potentially curing. \n\n\n\nBringing together multiple stakeholder groups\, including patients and industry\, the 2022 Patient BioForum is an opportunity to listen to patients’ understandings and experiences with unmet medical needs and facilitate progress towards a common understanding on unmet medical needs. \n\n\n\n \n\n\n\nSpeakers \n\n\n\n\nJoelle Khraiche\, EuropaBio\, Patient BioForum co-chair\n\n\n\n\n\nAnca Toma\, EPF\, Patient BioForum co-chair\n\n\n\n\n\nTobias S. Hagedorn\, Secretary of European Society for Phenylketonuria (ESPKU) and Managing Director of DIG PKU Germany\n\n\n\n\n\nPedro Franco\, Director Europe for Global Regulatory & Scientific Policy at Merck and Chair of EuropaBio’s OMP WG\n\n\n\n\nModerator \n\n\n\n\nAdrien Samson\, Healthcare Biotechnology Manager\, EuropaBio\n\n\n\n\n\nInvitation Only Event
URL:https://www.europabio.org/event/europabio-patient-bioforum-2022-toward-a-common-understanding-of-unmet-medical-needseuropabio-patient-bioforum-2022/
CATEGORIES:EuropaBio,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2022/11/Patient-BioForum-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20221206T090000
DTEND;TZID=Europe/Brussels:20221207T180000
DTSTAMP:20260707T183506
CREATED:20221116T144814Z
LAST-MODIFIED:20221116T145138Z
UID:5525-1670317200-1670436000@www.europabio.org
SUMMARY:17th European Bioplastics Conference
DESCRIPTION:The European Bioplastics Conference is Europe’s leading business and discussion forum within the global bioplastics sector. More and more brands and manufacturers are embracing the potential of biopolymers\, and policy makers are increasingly streamlining their efforts to create frameworks that benefit the growth of sustainable bio-industries. Now is the time to put bioplastics at the top of the agenda of a bio-based circular economy in Europe and beyond. \n\n\n\nThe registration for the 17th European Bioplastics Conference is now open and we are excited to welcome you on 6/7 December 2022 in Berlin or online.   \n\n\n\nThe hybrid format of this year’s event will allow you to join either in person at the Maritim proArte Hotel Berlin or comfortably log-in from your home base. Both of which offer unique networking opportunities  \n\n\n\nOf course\, we will also have an excellent exhibition on- and offline. Just choose the right type of booth to give your company visibility at the conference.  \n\n\n\n\nMore details
URL:https://www.europabio.org/event/17th-european-bioplastics-conference/
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2022/11/Vilnius-Statement-Event-600-×-260px-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20221213T110000
DTEND;TZID=Europe/Brussels:20221213T121500
DTSTAMP:20260707T183506
CREATED:20221006T094946Z
LAST-MODIFIED:20221207T150549Z
UID:5169-1670929200-1670933700@www.europabio.org
SUMMARY:SME BioForum 2022 - the voice of SMEs for a competitive\, sustainable and healthy Europe
DESCRIPTION:EuropaBio – the European Association for Bioindustries is delighted to invite you to its first public SME BioForum event – “SME BioForum 2022 – the voice of SMEs for a competitive\, sustainable and healthy Europe.” \n\n\n\nThroughout 2022\, EuropaBio SME Platform\, representing Europe’s biotechnology SME community across healthcare and industrial biotechnology\, organised two inaugural SME BioForum sessions. The Platform gathered European SME executives to discuss the latest biotechnology commercial developments\, company challenges\, and how the European landscape impacts their ability to grow and deliver products and services to the market. \n\n\n\nIn our first session dedicated to Advanced Therapy Medicinal Products (ATMPs)\, SME executives discussed their main challenges to growth\, focusing on Europe’s Market fragmentation\, Regulatory pathways and other bottlenecks. The second SME BioForum session dedicated to Europe’s Green transition was hosted at EuropaBio’s flagship conference\, the European Forum for Industrial Biotechnology and the Bioeconomy in Vilnius\, Lithuania. In this session\, SME leaders discussed how European SMEs are driving Europe’s Green transition through Biomanufacturing\, Incentives for disruptive technologies and Data use and Digital applications. \n\n\n\nClosing this year\, EuropaBio will host this online event. Our SME participants and European policymakers will join us to present and debate the latest policy developments for ATMPs and Europe’s Green transition and share their recommendations for achieving a competitive\, sustainable\, healthy Europe. \n\n\n\nJoin us online for an engaging discussion on December 13\, 11h00 – 12h15 CET. \n\n\n\nSpeakers \n\n\n\n\nAhmed Bouzidi\, Managing Director Europe & VP International BD\, Trinomab Biotech\n\n\n\nLinda Dijkshoorn\, CEO\, EV Biotech\n\n\n\nPaschalia Koufokotsiou\, Pharmaceutical and Health Policy\, DG SANTE\, European Commission\n\n\n\nMiranda Lindsay-Fynn\, Commercial Director\, Bio-Sep\n\n\n\nAndré Meyer\, SME Envoy Network\, Outreach activities coordination\, DG GROW\, European Commission\n\n\n\nMaria Luísa Nolli\, EuropaBio SME Platform Chair\n\n\n\nClaire Skentelbery\, EuropaBio Director-General\n\n\n\nVivian Tseveleki\, COO\, Theracell\n\n\n\nTal Zeltzer\, CTO\, Phytolon\n\n\n\n\n\nRegister here
URL:https://www.europabio.org/event/sme-bioforum-2022-the-voice-of-smes-for-a-competitive-sustainable-and-healthy-europe/
CATEGORIES:SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2022/10/Event-Page.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20221216T140000
DTEND;TZID=Europe/Brussels:20221216T160000
DTSTAMP:20260707T183506
CREATED:20221213T132138Z
LAST-MODIFIED:20221213T132140Z
UID:5590-1671199200-1671206400@www.europabio.org
SUMMARY:Biocatalytic Total Synthesis
DESCRIPTION:14:00 – 14:30 CETHarnessing the chemistry of plant natural product biosynthesis Prof. Dr. Sarah O’ConnorDepartment of Natural Product Biosynthesis\, Max Planck Institute for Chemical Ecology\, 07745 Jena\, Germany14:30 – 15:00 CETIntermolecular Diels-Alderases: Discovery and Applications in Natural Product Synthesis Prof. Dr. Xiaoguang LeiDepartment of Chemical Biology\, College of Chemistry and Molecular Engineering\, Peking University (PKU)\, Beijing 100871\, China15:00 – 15:30 CETEnzymatic Total Synthesis Approaches to Solve Enigmatic Biosynthetic Pathways and to Generate New Natural Product Analogues Prof. Jürgen Rohr\, Ph.D.\, FRSCCollege of Pharmacy\, University of Kentucky\, Lexington\, KY\, USA15:30 – 16:00 CETBiocatalysis in ring assembly and late-stage C-H functionalization of complex molecules Prof. Dr. David H. ShermanUniversity of Michigan\, Life Sciences Institute\, Departments of Medicinal Chemistry\, Chemistry\, Microbiology & Immunology\, Ann Arbor\, Michigan\, USA\n\n\n\nThis webinar is organised by ESAB – the European Society of Applied Biocatalysis\, which aims at promoting the development of Applied Biocatalysis throughout Europe.
URL:https://www.europabio.org/event/biocatalytic-total-synthesis/
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2022/12/Event-Page.png
END:VEVENT
END:VCALENDAR